July 2022. MRC Scientist Kelly Nguyen wins the prestigious Eppendorf Prize for her work about splicing and telomere biology. At the EMBL ceremony details were provided. In the exclusive interview with B2Bioworld she reveals more. Peter Fruhstorfer, CEO of Eppendorf explains business reasons of Eppendorf to support scientists including prize money who already are publicly funded. Nature Editor Angela Eggleston points to neglected questions in telomerase research.Reading time: 7 min
Read Now: |
B2Bioworld offers you background information
Christof von Kalle, at the time Head of Germany’s National Center for Tumor Diseases on new approaches to achieve tangible clinical results – or to manoeuvring into dead ends
Pascale Cossart, Professor at Institut Pasteur, Paris and Head of Unité des Interactions Bactéries-Cellules
Do’s and don’ts developing and selling viable tests for medical, agricultural, or food diagnostics in poor resource countries.
On voice-assistants, clinical trials, pathologies, and the COVID-19 bet. Includes interview with Guy Fagherazzi, Luxembourg Institute of Health
- open access